Your browser doesn't support javascript.
loading
May Measurement Month 2017 in Chile-Americas.
Lanas, Fernando; García, María Soledad; Paccot, Melanie; Peña, Jimena; Torres, Pamela; Beaney, Thomas; Kobeissi, Elsa; Poulter, Neil R.
Affiliation
  • Lanas F; Universidad de La Frontera, Facultad de Medicina, Departamento de Medicina Interna, M Mont 112 Temuco, Chile.
  • García MS; Cardiovascular Diseases Program, Superviser Physician, Servicio de Salud Araucanía Sur, Arturo Prat 969, Temuco, Chile.
  • Paccot M; Chair Department of Non-Communicable Disease, Ministerio de Salud de Chile, Enrique Mac Iver 541, Santiago, Región Metropolitana, Chile.
  • Peña J; Consultorio Miraflores, Miraflores 1369, Temuco, Chile.
  • Torres P; Departamento de Salud Municipal, Valentin Letelier 415, Villarrica, Chile.
  • Beaney T; Imperial Clinical Trials Unit, Imperial College London, Stadium House, 68 Wood Lane, London, UK.
  • Kobeissi E; Imperial Clinical Trials Unit, Imperial College London, Stadium House, 68 Wood Lane, London, UK.
  • Poulter NR; Imperial Clinical Trials Unit, Imperial College London, Stadium House, 68 Wood Lane, London, UK.
Eur Heart J Suppl ; 21(Suppl D): D34-D36, 2019 Apr.
Article de En | MEDLINE | ID: mdl-31043872
Elevated blood pressure (BP) is a growing burden worldwide, leading to over 10 million deaths each year. May Measurement Month (MMM) is a global initiative aimed at raising awareness of high BP and to act as a temporary solution to the lack of screening programmes worldwide. National Health Surveys, PURE and CESCAS Chilean cohorts have shown a high prevalence of hypertension, with a significant proportion of people unaware of being hypertensive or under treatment but with uncontrolled BP. An opportunistic cross-sectional survey of volunteers aged ≥18 was carried out in May 2017. BP measurement, the definition of hypertension and statistical analysis followed the MMM protocol. Sixty-seven sites participated. Most screening sites were National Heath Public System outpatient clinics, mainly in the 9th region of the country. In addition, clinical research sites and private clinics participated. Overall, 4754 individuals were screened during MMM17. After multiple imputations, 1153 (24.2%) had hypertension. Of individuals not receiving anti-hypertensive medication, 653 (15.3%) were hypertensive. Of the 500 individuals receiving anti-hypertensive medication, 162 (32.5%) had uncontrolled BP. MMM17 was one of the largest BP screening campaigns performed in Chile. It demonstrated a high proportion of hypertension among screenees with a low proportion the individuals with controlled hypertension in the community. The high percentage of persons untreated or with uncontrolled hypertension whilst on pharmacologic treatment suggests that systematic screening programmes may be a useful tool to improve hypertension control in Chile.

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Guideline / Risk_factors_studies Pays/Région comme sujet: America do sul / Chile Langue: En Journal: Eur Heart J Suppl Année: 2019 Type de document: Article Pays d'affiliation: Chili Pays de publication: Royaume-Uni

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Guideline / Risk_factors_studies Pays/Région comme sujet: America do sul / Chile Langue: En Journal: Eur Heart J Suppl Année: 2019 Type de document: Article Pays d'affiliation: Chili Pays de publication: Royaume-Uni